ATE307340T1 - Verfahren für die feststellung von asthma suszeptibilität - Google Patents

Verfahren für die feststellung von asthma suszeptibilität

Info

Publication number
ATE307340T1
ATE307340T1 AT99968477T AT99968477T ATE307340T1 AT E307340 T1 ATE307340 T1 AT E307340T1 AT 99968477 T AT99968477 T AT 99968477T AT 99968477 T AT99968477 T AT 99968477T AT E307340 T1 ATE307340 T1 AT E307340T1
Authority
AT
Austria
Prior art keywords
asthma
asthma susceptibility
severity
disclosed
determining whether
Prior art date
Application number
AT99968477T
Other languages
English (en)
Inventor
Gurjit K Khurana Hershey
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Application granted granted Critical
Publication of ATE307340T1 publication Critical patent/ATE307340T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5406IL-4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99968477T 1998-12-11 1999-12-10 Verfahren für die feststellung von asthma suszeptibilität ATE307340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11193698P 1998-12-11 1998-12-11
PCT/US1999/029417 WO2000034789A2 (en) 1998-12-11 1999-12-10 Method for determining asthma susceptibility

Publications (1)

Publication Number Publication Date
ATE307340T1 true ATE307340T1 (de) 2005-11-15

Family

ID=22341233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968477T ATE307340T1 (de) 1998-12-11 1999-12-10 Verfahren für die feststellung von asthma suszeptibilität

Country Status (9)

Country Link
US (1) US6379890B1 (de)
EP (1) EP1137947B1 (de)
JP (1) JP2002532073A (de)
AT (1) ATE307340T1 (de)
AU (1) AU2588600A (de)
CA (1) CA2354673A1 (de)
DE (1) DE69927846T2 (de)
ES (1) ES2249061T3 (de)
WO (1) WO2000034789A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
US7208579B2 (en) * 2003-05-30 2007-04-24 The Regents Of The University Of California IL4 receptor antagonists for horse, dog and cat
US7732135B2 (en) 2003-08-05 2010-06-08 Hershey Gurjit K Khurana Genetic markers of food allergy
AU2006216514C1 (en) 2005-02-25 2012-09-27 Isis Pharmaceuticals, Inc. Compositions and their uses directed to IL-4R alpha
JP2009510174A (ja) * 2005-10-03 2009-03-12 アイシス ファーマシューティカルズ, インコーポレーテッド ブデソニドおよびil−4受容体アルファを標的化するアンチセンスオリゴヌクレオチドを用いた併用療法
CA2625446A1 (en) * 2005-10-13 2007-04-19 Friedrich-Alexander-Universitaet Erlangen-Nuernberg Means and methods for the prediction of joint destruction
US7378717B2 (en) * 2005-11-15 2008-05-27 International Business Machines Corporation Semiconductor optical sensors
US20070270366A1 (en) * 2005-12-20 2007-11-22 Karras James G Double stranded nucleic acid molecules targeted to il-4 receptor alpha
EP2076777A4 (de) * 2006-09-28 2009-12-30 Centocor Ortho Biotech Inc Verfahren zur erkennung von il-16-aktivität und modulation von il-16-aktivität auf basis der proxy-konzentrationen von phosphoryliertem stat6
EP2141499A1 (de) * 2008-07-02 2010-01-06 Apoptec AG COPD-Diagnose
EP2414520A2 (de) 2009-03-31 2012-02-08 Altair Therapeutics, Inc. Verfahren zur modulation einer immunantwort auf eine virusinfektion
US20220033489A1 (en) * 2018-12-04 2022-02-03 The Children's Medical Center Corporation Methods and compositions for treating asthma
WO2021161997A1 (ja) * 2020-02-10 2021-08-19 国立大学法人山口大学 ヒトインターロイキン4受容体の変異ポリペプチド、及びm2マクロファージへの分化又は分極誘導剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor
JPH11332567A (ja) * 1998-05-22 1999-12-07 Dai Ichi Seiyaku Co Ltd アトピー体質の判定方法

Also Published As

Publication number Publication date
DE69927846T2 (de) 2006-07-13
EP1137947A2 (de) 2001-10-04
WO2000034789A2 (en) 2000-06-15
EP1137947B1 (de) 2005-10-19
JP2002532073A (ja) 2002-10-02
ES2249061T3 (es) 2006-03-16
DE69927846D1 (de) 2006-03-02
AU2588600A (en) 2000-06-26
US6379890B1 (en) 2002-04-30
WO2000034789A3 (en) 2000-09-08
CA2354673A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
DE69927846D1 (de) Verfahren für die feststellung von asthma suszeptibilität
DE69925625D1 (de) Verfahren und vorrichtung zum vorhersagen von menschlichen kognitiven leistung
DE69920006D1 (de) Verfahren und vorrichtung für elektrochemische messungen unter verwendung von statistischen methoden
CA2316361A1 (en) A method for predicting an abnormal level of clotting proteins
ES2164888T3 (es) Un metodo y un aparato para predecir la presencia de desequilibrios congenitos y adquiridos y estados terapeuticos.
ATE302976T1 (de) Anlage und verfahren zum vorhersagen von menschlichen kognitiven leistungen unter verwendung von aktigraphdaten
ATE339196T1 (de) Zelladhäsionsinhibitoren
ATE402518T1 (de) Verfahren zum bestimmen eines numerischen wertes für die zeitliche dauer eines sich periodisch wiederholenden impulsförmigen signals, und vorrichtung zur durchführung eines solchen verfahrens
ATE447878T1 (de) Verfahren und vorrichtung zur augenverfolgung
ATE334445T1 (de) Verfahren, vorrichtung, medium und programm zur aufnahme und zum verlassen von mehreren fäden in einem vielfadenprozessor
DE10196984T1 (de) Verfahren und System für die Vorhersage von Ursachen von Netzwerk-Service-Ausfällen unter Benutzung der Zeit-Domänen Korrelation
DE69531077D1 (de) Verfahren und Vorrichtung mit Benutzereinwirkung der Art Erproben-und-Kaufen, die es ermöglicht, Software zu erproben
ATE476719T1 (de) Verhaltensbasierte anpassung von computersystemen
ATE277401T1 (de) Vorrichtung und verfahren zur erkennung von gefühlen in der menschlichen stimme
IT1208769B (it) Teristiche varianti nel tempo procedimento e dispositivo per la cancellazione numerica dell eco generato in collegamenti con carat
DE59915174D1 (de) Verfahren und vorrichtung zum ermitteln der temper
ATE514297T1 (de) Verfahren und system zur bereitstellung eines einzigen ruhestellungs-/messanforderungselements für vereinte kanäle in einem drahtlosen lokalen netzwerk gemäss 802.11
ATE404118T1 (de) System für kontinuierliche leistungstests
DE69621499D1 (de) Kalkulator zur Abschätzung der Maximalwahrscheinlichkeits-Abfolge und Verfahren hierfür
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
DE60309453D1 (de) Vorrichtung zur verwaltung von einem patientenbehandlungsprogramm
GB2349476A (en) Assessment of corrosion
BR0015171A (pt) Aparelho e método para análise de dados de performance e de falha
ATE186121T1 (de) Verfahren zur bestimmung des präthrombotischen status
ATE394360T1 (de) Verfahren zur verminderung von von der verwendung von fluorphosphitkatalysatoren herruehrenden fluoridverunreinigungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1137947

Country of ref document: EP

REN Ceased due to non-payment of the annual fee